Summary & Overview
HCPCS Level II J1436: Injection, Etidronate Disodium, per 300 mg
HCPCS Level II code J1436 designates the injection of etidronate disodium, billed per 300 mg unit. This code is nationally relevant for payers and providers involved in administering parenteral bisphosphonate therapy in outpatient and ambulatory infusion settings. Accurate coding ensures proper identification of the drug product and supports claims processing and utilization tracking across commercial and public payers.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for etidronate injections, common sites of service, and the role of J1436 in medical billing. The publication outlines benchmarks and reimbursement considerations, payer coverage patterns, and recent policy notes affecting injectable drug coding where available. Clinical implications, coding nuances, and administrative considerations for claims submission are summarized to inform billing teams, pharmacists, and clinicians. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code J1436 represents the injection of etidronate disodium, measured per 300 mg. This code is used for billing a specific parenteral administration of etidronate disodium, a bisphosphonate agent.
-
Service type: Injectable pharmaceutical administration
-
Typical site of service: Outpatient infusion clinic or ambulatory care setting
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with metabolic bone disease or heterotopic ossification for whom intravenous or intramuscular etidronate disodium therapy is clinically indicated. The medication described by billing code J1436 (Injection, etidronate disodium, per 300 mg) is administered in an outpatient infusion clinic, ambulatory surgical center, or physician office with appropriately trained nursing staff. The workflow begins with physician assessment (history, physical, and relevant imaging or laboratory evaluation), documentation of indication and informed consent, verification of medication dose and lot, and ordering of the injection. Nursing performs venous access if IV administration is required, prepares the medication per manufacturer instructions, administers the injection, monitors the patient for adverse reactions during and after administration, documents medication administration in the medical record, and bills the payer using J1436 with applicable modifiers reflecting the encounter circumstance. Typical monitoring includes vital signs before and after administration and assessment for hypersensitivity. The usual payer interactions involve prior authorization for off-label or high-cost indications and submission of medical record documentation supporting the diagnosis and necessity of J1436.
Coding Specifications
| Modifier | Description | When to Use |
|---|